Attridge S R, Voss E, Manning P A
Department of Microbiology and Immunology, University of Adelaide, Australia.
J Biotechnol. 1999 Aug 20;73(2-3):109-17. doi: 10.1016/s0168-1656(99)00114-5.
Vibrio cholerae O1 strains are classified into one of two biotypes, classical and E1 Tor, the latter being primarily responsible for cholera cases worldwide since 1961. Recent studies in our laboratory have focused upon the pathogenic and vaccine significance of the toxin-coregulated pili (TCP) produced by strains of E1 Tor biotype. Mutants in which the tcpA gene (encoding the pilin subunit protein) has been inactivated are dramatically attenuated in the infant mouse cholera model, showing markedly reduced colonisation potential in mixed-infection competition experiments. Significantly, in the vaccine context, antibodies to TCP are sufficient to prevent experimental infection, although our data suggest that this protective effect might be limited to strains of homologous biotype. Since we have shown that tcpA sequences are conserved within a biotype but differ between biotypes, this latter observation suggests that the biotype-restricted pilin epitopes might have greater vaccine significance. Similar studies indicate that TCP also play a critical role in colonisation by strains of the recently-recognised O139 serogroup, which is thought to have evolved from an O1 E1 Tor strain. In contrast to the effect of introducing mutations in the tcpA gene, strains carrying inactivated mshA genes (encoding the subunit of the mannose-sensitive haemagglutinin pilus) show unaltered in vivo behaviour. Consistent with this finding is our inability to demonstrate any protective effect associated with antibodies to MSHA. Ongoing approaches to vaccine development are variously aimed at improving the immunogenicity of the current inactivated whole-cell vaccine, or assessing the field efficacy of a promising live attenuated strain. The possible implications of our findings are discussed in relation to both of these options.
霍乱弧菌O1菌株分为两个生物型之一,即古典生物型和埃尔托生物型,自1961年以来,后者是全球霍乱病例的主要致病菌。我们实验室最近的研究集中在埃尔托生物型菌株产生的毒素共调节菌毛(TCP)的致病和疫苗意义上。tcpA基因(编码菌毛蛋白亚基)失活的突变体在幼鼠霍乱模型中显著减毒,在混合感染竞争实验中显示出明显降低的定殖潜力。重要的是,在疫苗方面,针对TCP的抗体足以预防实验性感染,尽管我们的数据表明这种保护作用可能仅限于同源生物型的菌株。由于我们已经表明tcpA序列在一个生物型内是保守的,但在不同生物型之间存在差异,后一观察结果表明生物型限制的菌毛蛋白表位可能具有更大的疫苗意义。类似的研究表明,TCP在最近确认的O139血清群菌株的定殖中也起关键作用,该血清群被认为是从O1埃尔托菌株进化而来的。与在tcpA基因中引入突变的效果相反,携带失活mshA基因(编码甘露糖敏感血凝菌毛的亚基)的菌株在体内的行为未改变。与这一发现一致的是,我们无法证明与针对MSHA的抗体相关的任何保护作用。正在进行的疫苗开发方法旨在不同程度地提高当前灭活全细胞疫苗的免疫原性,或评估一种有前景的减毒活菌株的现场效力。我们的研究结果对这两种选择的可能影响进行了讨论。